Record growth for life science tech firm as MES adoption increases globally

James O’Brien, global MES business unit lead at Zenith Technologies.

Zenith Technologies surpasses the €20 million milestone for sales of its manufacturing execution system (MES) services.

Commenting on the growth trend, James O’Brien, global MES business unit lead at Zenith Technologies, said: “MES has been the fastest growing segment of our offering and now represents almost a third of our business. Factors such as a greater regulatory focus on data integrity and customer demand for improved production performance have led to growing use of MES solutions within the pharmaceutical, biotech and medical device industries, which have traditionally been slow to adopt new technologies.

“The UK in particular is quickly becoming an MES centre of excellence, with MES sales representing 70% of our business in this market. Similarly, the US & Asia markets offer huge growth potential as the adoption of MES within the life science industry continues to grow across the globe.”

Zenith Technologies now works with nine of the top 10 pharmaceutical companies globally and during 2016 its team of engineers grew by almost 40% to over 700 employees.

To strengthen its ability to support customers in Europe, the US and Asia and accelerate further growth, the company has recently formed a number of strategic partnerships with MES technology providers, including Werum IT Solutions , AspenTech and LZ Lifescience. This will enable Zenith to support customers worldwide with on-site implementations of MES solutions designed to improve productivity, meet regulatory requirements during life science manufacturing and ultimately deliver vital medicines to patients as efficiently as possible.